Efficacy and safety of traditional medical therapies for chronic constipation: Systematic review

被引:270
作者
Ramkumar, D [1 ]
Rao, SSC [1 ]
机构
[1] Univ Iowa, Carver Coll Med, Div Gastroenterol, Iowa City, IA 52242 USA
关键词
D O I
10.1111/j.1572-0241.2005.40925.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Constipation is common, and its treatment is unsatisfactory. Although many agents have been tried, there are limited data to support their use. Our aim was to undertake a systematic review of the efficacy and safety of traditional medical therapies for chronic constipation and to make evidence-based recommendations. Methods: We searched the English literature for drug trials evaluating treatment of constipation by using MEDLINE and PUBMED databases from 1966 to 2003. Only studies that were randomized, conducted on adult subjects, and published as full manuscripts were included. Studies were assigned a quality score based on published methodology. Standard forms were used to abstract data regarding study design, duration, outcome measures, and adverse events. By using the cumulative evidence of published data for each agent, recommendations were made regarding their use following the United States Preventive Services Task Force guidelines. Results: Good evidence (Grade A) was found to support the use of polyethylene glycol (PEG) and tegaserod. Moderate evidence (Grade B) was found to support the use of psyllium, and lactulose. There was a paucity of quality data regarding many commonly used agents including milk of magnesia, senna, bisacodyl, and stool softeners. Conclusions: There is good evidence to support the use of PEG, tegaserod, lactulose, and psyllium. Surprisingly, there is a paucity of trials for many commonly used agents. These aspects should be considered when designing trials comparing new agents with traditional therapies because their use may not be well validated.
引用
收藏
页码:936 / 971
页数:36
相关论文
共 71 条
[1]  
ANDERSON AS, 1985, HUM NUTR-APPL NUTR, V39A, P202
[2]  
ANDORSKY RI, 1990, AM J GASTROENTEROL, V85, P261
[3]  
Ashraf W, 1995, ALIMENT PHARM THER, V9, P639, DOI 10.1111/j.1365-2036.1995.tb00433.x
[4]   Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation [J].
Attar, A ;
Lémann, M ;
Ferguson, A ;
Halphen, M ;
Boutron, MC ;
Flourié, B ;
Alix, E ;
Salmeron, M ;
Guillemot, F ;
Chaussade, S ;
Ménard, AM ;
Moreau, J ;
Naudin, G ;
Barthet, M .
GUT, 1999, 44 (02) :226-230
[5]   EFFECT OF WHEAT BRAN IN TREATMENT OF CHRONIC NONORGANIC CONSTIPATION - A DOUBLE-BLIND CONTROLLED TRIAL [J].
BADIALI, D ;
CORAZZIARI, E ;
HABIB, FI ;
TOMEI, E ;
BAUSANO, G ;
MAGRINI, P ;
ANZINI, F ;
TORSOLI, A .
DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (02) :349-356
[6]   THE LAXATIVE EFFECTS OF LACTULOSE IN NORMAL AND CONSTIPATED SUBJECTS [J].
BASS, P ;
DENNIS, S .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1981, 3 :23-28
[7]   CONSTIPATION IN LONG-STAY ELDERLY PATIENTS - ITS TREATMENT AND PREVENTION BY LACTULOSE, "POLOXALKOL-DIHYDROXYANTHROQUINOLONE AND PHOSPHATE ENEMAS [J].
BROCKLEHURST, JC ;
KIRKLAND, JL ;
MARTIN, J ;
ASHFORD, J .
GERONTOLOGY, 1983, 29 (03) :181-184
[8]  
CASTLE SC, 1991, GERIATRICS, V46, P84
[9]   Comparison of efficacy and safety of two doses of two different polyethylene glycol-based laxatives in the treatment of constipation [J].
Chaussade, S ;
Minic, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (01) :165-172
[10]   MECHANISMS OF CONSTIPATION IN OLDER PERSONS AND EFFECTS OF FIBER COMPARED WITH PLACEBO [J].
CHESKIN, LJ ;
KAMAL, N ;
CROWELL, MD ;
SCHUSTER, MM ;
WHITEHEAD, WE .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1995, 43 (06) :666-669